ALEXANDRIA, Va., June 12 -- United States Patent no. 12,299,884, issued on May 13, was assigned to Insitro Inc. (South San Francisco, Calif.).
"Machine-learning-enabled predictive biomarker discovery and patient stratification using standard-of-care data" was invented by Christopher Probert (Mill Valley, Calif.), Zachary Ryan McCaw (Chapel Hill, N.C.), Daphne Koller (Portola Valley, Calif.) and Anna Shcherbina (San Bruno, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates generally to biomarker discovery and patient stratification, and more specifically to machine learning techniques for discovering relevant biomarkers using data collected as part of the standard-of-care (So...